These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20410102)

  • 1. Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones.
    Lee WC; Kang D; Causevic E; Herdt AR; Eckman EA; Eckman CB
    J Neurosci; 2010 Apr; 30(16):5489-97. PubMed ID: 20410102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological chaperones increase residual β-galactocerebrosidase activity in fibroblasts from Krabbe patients.
    Berardi AS; Pannuzzo G; Graziano A; Costantino-Ceccarini E; Piomboni P; Luddi A
    Mol Genet Metab; 2014 Aug; 112(4):294-301. PubMed ID: 24913062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Trafficking and Processing of GALC Mutants Correlates with Globoid Cell Leukodystrophy Severity.
    Shin D; Feltri ML; Wrabetz L
    J Neurosci; 2016 Feb; 36(6):1858-70. PubMed ID: 26865610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chaperone therapy for Krabbe disease: potential for late-onset GALC mutations.
    Hossain MA; Higaki K; Saito S; Ohno K; Sakuraba H; Nanba E; Suzuki Y; Ozono K; Sakai N
    J Hum Genet; 2015 Sep; 60(9):539-45. PubMed ID: 26108143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form.
    Hossain MA; Otomo T; Saito S; Ohno K; Sakuraba H; Hamada Y; Ozono K; Sakai N
    Gene; 2014 Jan; 534(2):144-54. PubMed ID: 24252386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult onset globoid cell leukodystrophy (Krabbe disease): analysis of galactosylceramidase cDNA from four Japanese patients.
    Furuya H; Kukita Y; Nagano S; Sakai Y; Yamashita Y; Fukuyama H; Inatomi Y; Saito Y; Koike R; Tsuji S; Fukumaki Y; Hayashi K; Kobayashi T
    Hum Genet; 1997 Sep; 100(3-4):450-6. PubMed ID: 9272171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Mechanisms of Disease Pathogenesis Differ in Krabbe Disease Variants.
    Spratley SJ; Hill CH; Viuff AH; Edgar JR; Skjødt K; Deane JE
    Traffic; 2016 Aug; 17(8):908-22. PubMed ID: 27126738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones.
    Spratley SJ; Deane JE
    J Neurosci Res; 2016 Nov; 94(11):1203-19. PubMed ID: 27638604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human iPSC-based neurodevelopmental models of globoid cell leukodystrophy uncover patient- and cell type-specific disease phenotypes.
    Mangiameli E; Cecchele A; Morena F; Sanvito F; Matafora V; Cattaneo A; Della Volpe L; Gnani D; Paulis M; Susani L; Martino S; Di Micco R; Bachi A; Gritti A
    Stem Cell Reports; 2021 Jun; 16(6):1478-1495. PubMed ID: 33989519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-based high-throughput screening identifies galactocerebrosidase enhancers as potential small-molecule therapies for Krabbe's disease.
    Jang DS; Ye W; Guimei T; Solomon M; Southall N; Hu X; Marugan J; Ferrer M; Maegawa GH
    J Neurosci Res; 2016 Nov; 94(11):1231-45. PubMed ID: 27638606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the rhesus monkey galactocerebrosidase (GALC) cDNA and gene and identification of the mutation causing globoid cell leukodystrophy (Krabbe disease) in this primate.
    Luzi P; Rafi MA; Victoria T; Baskin GB; Wenger DA
    Genomics; 1997 Jun; 42(2):319-24. PubMed ID: 9192853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of galactosylceramidase (GALC) expression in the twitcher mouse model of globoid cell leukodystrophy (GLD) is caused by nonsense-mediated mRNA decay (NMD).
    Lee WC; Tsoi YK; Dickey CA; Delucia MW; Dickson DW; Eckman CB
    Neurobiol Dis; 2006 Aug; 23(2):273-80. PubMed ID: 16759875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual galactosylsphingosine (psychosine) beta-galactosidase activities and associated GALC mutations in late and very late onset Krabbe disease.
    Harzer K; Knoblich R; Rolfs A; Bauer P; Eggers J
    Clin Chim Acta; 2002 Mar; 317(1-2):77-84. PubMed ID: 11814461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics simulations to decipher the structural and functional consequences of pathogenic missense mutations in the galactosylceramidase (GALC) protein causing Krabbe's disease.
    D TK; Jain N; Kumar S U; Jena PP; Ramamoorthy S; Priya Doss C G; Zayed H
    J Biomol Struct Dyn; 2021 Mar; 39(5):1795-1810. PubMed ID: 32186243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease.
    Tappino B; Biancheri R; Mort M; Regis S; Corsolini F; Rossi A; Stroppiano M; Lualdi S; Fiumara A; Bembi B; Di Rocco M; Cooper DN; Filocamo M
    Hum Mutat; 2010 Dec; 31(12):E1894-914. PubMed ID: 20886637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of late-life globoid cell leukodystrophy.
    De Gasperi R; Gama Sosa MA; Sartorato E; Battistini S; Raghavan S; Kolodny EH
    Hum Mutat; 1999; 14(3):256-62. PubMed ID: 10477434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular heterogeneity of Krabbe disease.
    Fu L; Inui K; Nishigaki T; Tatsumi N; Tsukamoto H; Kokubu C; Muramatsu T; Okada S
    J Inherit Metab Dis; 1999 Apr; 22(2):155-62. PubMed ID: 10234611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a mouse with low galactocerebrosidase activity by gene targeting: a new model of globoid cell leukodystrophy (Krabbe disease).
    Luzi P; Rafi MA; Zaka M; Curtis M; Vanier MT; Wenger DA
    Mol Genet Metab; 2001 Jul; 73(3):211-23. PubMed ID: 11461188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease.
    Iacono D; Koga S; Peng H; Manavalan A; Daiker J; Castanedes-Casey M; Martin NB; Herdt AR; Gelb MH; Dickson DW; Lee CW
    Neurobiol Dis; 2022 Nov; 174():105862. PubMed ID: 36113749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
    Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
    J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.